4//SEC Filing
Grant Sean 4
Accession 0001415889-24-010473
CIK 0001831828other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 9:32 PM ET
Size
39.9 KB
Accession
0001415889-24-010473
Insider Transaction Report
Form 4
Grant Sean
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Class A Common Stock
2024-04-03$38.22/sh−387$14,793→ 1,233 total(indirect: As custodian for UTMA account) - Sale
Class A Common Stock
2024-04-03$38.20/sh−78$2,979→ 257 total(indirect: By IRA) - Sale
Class A Common Stock
2024-04-03$38.65/sh−10,988$424,708→ 85,346 total - Sale
Class A Common Stock
2024-04-03$38.13/sh−11,648$444,080→ 73,698 total - Sale
Class A Common Stock
2024-04-03$39.25/sh−7,361$288,927→ 66,337 total - Sale
Class A Common Stock
2024-04-03$39.22/sh−80$3,137→ 177 total(indirect: By IRA) - Sale
Class A Common Stock
2024-04-03$39.19/sh−366$14,342→ 867 total(indirect: As Custodian for UTMA account) - Sale
Class A Common Stock
2024-04-03$38.22/sh−672$25,686→ 2,144 total(indirect: By IRA) - Sale
Class A Common Stock
2024-04-03$40.06/sh−1,505$60,286→ 0 total(indirect: By IRA) - Sale
Class A Common Stock
2024-04-03$38.23/sh−201$7,684→ 656 total(indirect: By Spouse) - Exercise/Conversion
Class A Common Stock
2024-04-03$14.87/sh+99,828$1,484,442→ 166,165 total - Sale
Class A Common Stock
2024-04-03$40.06/sh−867$34,731→ 0 total(indirect: As Custodian for UTMA account) - Sale
Class A Common Stock
2024-04-03$39.19/sh−639$25,044→ 1,505 total(indirect: By IRA) - Sale
Class A Common Stock
2024-04-03$39.20/sh−203$7,957→ 453 total(indirect: By Spouse) - Sale
Class A Common Stock
2024-04-03$38.22/sh−3,112$118,950→ 14,909 total(indirect: By Trust) - Sale
Class A Common Stock
2024-04-03$40.06/sh−177$7,090→ 0 total(indirect: By IRA) - Sale
Class A Common Stock
2024-04-03$40.05/sh−453$18,144→ 0 total(indirect: By Spouse) - Sale
Class A Common Stock
2024-04-03$39.19/sh−2,944$115,384→ 11,965 total(indirect: By Trust) - Sale
Class A Common Stock
2024-04-03$40.05/sh−69,831$2,796,801→ 96,334 total - Sale
Class A Common Stock
2024-04-03$40.06/sh−6,965$278,997→ 5,000 total(indirect: By Trust) - Exercise/Conversion
Stock Option (right to buy)
2024-04-03−99,828→ 80,172 totalExercise: $14.87Exp: 2031-07-12→ Class A Common Stock (99,828 underlying)
Footnotes (11)
- [F1]Includes 1,939 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on March 13, 2024.
- [F10]The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
- [F11]1/4 of 180,000 shares subject to the option vested on July 12, 2022, and 1/48 of the shares vest monthly thereafter.
- [F2]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.36, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.25 to $39.225, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.52, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F5]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.075 to $39.35, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F6]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.64, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F7]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.67, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F8]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.82 to $40.355, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F9]The shares were acquired through a custodial account established for an immediate family member of the Reporting Person pursuant to the Uniform Transfers to Minors Act, for which the Reporting Person serves as a custodian.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001872792
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 9:32 PM ET
- Size
- 39.9 KB